COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness

A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine

(2021) Laurence Chu et al.   VACCINE

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

From Vaccine Nationalism to Vaccine Equity — Finding a Path Forward

(2021) Ingrid T. Katz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

(2021) Xinxue Liu et al.   LANCET

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

(2021) Alberto M Borobia et al.   LANCET

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

(2021) Amy Flaxman et al.   LANCET

Effectiveness of COVID‐19 vaccines: findings from real world studies

(2021) David A Henry et al.   MEDICAL JOURNAL OF AUSTRALIA

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

(2021) Ugur Sahin et al.   NATURE

Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality

(2021) Benjamin J. Cowling et al.   NATURE MEDICINE

Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells

(2021) Jose Mateus et al.   SCIENCE

SARS-CoV-2 vaccines in development

(2020) Florian Krammer   NATURE

Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis

(2020) Jenny L. Schnyder et al.   Travel Medicine and Infectious Disease

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

(2020) Jordan R. Barrett et al.   NATURE MEDICINE

Intradermal travel vaccinations-when less means more

(2019) Frieder Schaumburg et al.   Travel Medicine and Infectious Disease

Introducing new vaccines in low- and middle-income countries: challenges and approaches

(2019) Adrienne Guignard et al.   Expert Review of Vaccines

Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak — Preliminary Report

(2018) Steve Ahuka-Mundeke et al.   NEW ENGLAND JOURNAL OF MEDICINE